Bausch & Lomb price to free cash flow BLCO

Market value divided by free cash flow over the last twelve months, since 2023.

Today, Oct 23, 2026: 45.5×
4-year median: 44.8×
Against its 4-year history: 58th; percentile: 0 is its lowest day, 100 its highest
4-year range: 32.7× to 63.0×
Peer median: 19.2×

Bausch & Lomb's price to free cash flow is 45.5× as of Oct 23, 2026.

That is above its 4-year median of 44.8×, close to the middle of its last 4 years.

Over that time it ranged from 32.7× in Mar 2023 to 63.0× in Jul 2023.

The median for 10 medical instruments and supplies stocks of a similar size is 19.2×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	45.5×	43.0×	47.0×
2025	n/m a value too high to mean anything
2024	n/m a value too high to mean anything
2023	59.6×	32.7×	63.0×

Against its peers

Companies in Medical - Instruments & Supplies nearest Bausch & Lomb's size, closest first, today.

Company	Price to free cash flow
BLCOBausch & Lomb	45.5×
MMSIMerit Medical Systems	27.4×
MSAMSA Safety	19.8×
HAEHaemonetics	18.5×
VNTVontier	12.1×
BMIBadger Meter	29.2×
ICUIICU Medical	27.3×
NVSTEnvista	15.3×
PODDInsulet	35.2×
GMEDGlobus Medical	14.5×
ALGNAlign Technology	17.3×
Peer median	19.2×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Bausch & Lomb

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.